Phathom Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 12.47 M | $138.50 M | 0.00% | 17.10% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 04/21/2026 | 7.46 M | $82.93 M | 0.00% | 10.24% |
| INVESCO LTD. | 05/12/2026 | 4.32 M | $48.02 M | 10.24% | 5.93% |
| BLACKROCK, INC. | 05/13/2026 | 4.06 M | $45.13 M | 14.24% | 5.57% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 4.02 M | $44.69 M | 93.21% | 5.52% |
| CARLYLE GROUP INC. | 05/08/2026 | 3.50 M | $38.85 M | 0.00% | 4.80% |
| 05/15/2026 | 2.58 M | $28.70 M | 100.00% | 3.54% | |
| NEA MANAGEMENT COMPANY, LLC | 05/15/2026 | 1.96 M | $21.78 M | 0.00% | 2.69% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.85 M | $20.55 M | 3.64% | 2.54% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 1.63 M | $18.08 M | -30.79% | 2.23% |
| CATALYS PACIFIC, LLC | 05/14/2026 | 1.49 M | $16.60 M | 4.54% | 2.05% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 1.42 M | $15.79 M | 8.76% | 1.95% |
| STATE STREET CORP | 05/15/2026 | 1.39 M | $15.41 M | 20.65% | 1.90% |
| WASATCH ADVISORS LP | 04/21/2026 | 1.34 M | $14.90 M | 0.69% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.33 M | $14.76 M | 23.72% | 1.82% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 1.21 M | $13.39 M | 100.00% | 1.65% |
| SUMMITTX CAPITAL, L.P. | 05/15/2026 | 995.89 K | $11.06 M | 92.32% | 1.37% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 994.50 K | $11.05 M | 100.00% | 1.36% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 925.00 K | $10.28 M | 100.00% | 1.27% |
| MARSHALL WACE, LLP | 05/15/2026 | 860.69 K | $9.56 M | 100.00% | 1.18% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 841.27 K | $9.35 M | 13.54% | 1.15% |
| 05/08/2026 | 666.03 K | $7.40 M | 100.00% | 0.91% | |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 626.20 K | $6.96 M | 59.73% | 0.86% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 625.00 K | $6.94 M | 100.00% | 0.86% |
| CITADEL ADVISORS LLC | 05/15/2026 | 515.90 K | $5.73 M | 644.44% | 0.71% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 482.14 K | $5.36 M | 734.39% | 0.66% |
| STEPSTONE GROUP LP | 05/15/2026 | 422.09 K | $4.69 M | 0.00% | 0.58% |
| NORTHERN TRUST CORP | 05/14/2026 | 414.96 K | $4.61 M | 16.41% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 409.02 K | $4.54 M | 2.79% | 0.56% |
| CITADEL ADVISORS LLC | 05/15/2026 | 383.06 K | $4.26 M | 23.05% | 0.53% |
| WOODLINE PARTNERS LP | 05/15/2026 | 369.05 K | $4.10 M | 97.05% | 0.51% |
| UBS GROUP AG | 05/05/2026 | 360.37 K | $4.00 M | 18.39% | 0.49% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 338.71 K | $3.76 M | 100.00% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 323.80 K | $3.60 M | 1.95% | 0.44% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 305.80 K | $3.40 M | 100.00% | 0.42% |
| TREXQUANT INVESTMENT LP | 05/15/2026 | 293.31 K | $3.26 M | 114.37% | 0.40% |
| JPMORGAN CHASE & CO | 05/13/2026 | 287.43 K | $3.03 M | -3.12% | 0.39% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 275.16 K | $3.06 M | 100.00% | 0.38% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 267.96 K | $2.98 M | 0.00% | 0.37% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 262.39 K | $2.92 M | -18.50% | 0.36% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 254.22 K | $2.82 M | 36.87% | 0.35% |
| AVIDITY PARTNERS MANAGEMENT LP | 05/28/2026 | 249.39 K | $2.77 M | 21.02% | 0.34% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 247.77 K | $2.75 M | -64.55% | 0.34% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 208.12 K | $2.31 M | -19.65% | 0.29% |
| BIRCHVIEW CAPITAL, LP | 05/15/2026 | 195.00 K | $2.17 M | 0.00% | 0.27% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 183.00 K | $2.03 M | -8.88% | 0.25% |
| XTX TOPCO LTD | 05/15/2026 | 160.50 K | $1.78 M | 307.36% | 0.22% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 05/13/2026 | 145.93 K | $1.62 M | 26.92% | 0.20% |
| GILDER GAGNON HOWE & CO LLC | 05/15/2026 | 139.89 K | $1.55 M | -3.64% | 0.19% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 132.46 K | $1.47 M | -49.26% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 224 institutional investors and hedge funds held shares of Phathom Pharmaceuticals Inc. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 12.47 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
Invesco Ltd.: 4.32 M
BlackRock, Inc.: 4.06 M
MILLENNIUM MANAGEMENT LLC: 4.02 M
Carlyle Group Inc.: 3.5 M
94.47% of Phathom Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 75.80 M shares in the last 24 months. This purchase volume represents approximately $842.14 M in transactions.